LAUSANNE, Switzerland, March 1, 2019 /PRNewswire/ — First randomized clinical trial comparing the efficacy and safety of combined doxycycline 40 mg modified release (DMR) and ivermectin […]
CARsgen Therapeutics Receives IND Clearance for BCMA-CAR-T Cells from the NMPA
SHANGHAI, March 1, 2019 /PRNewswire/ — CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, today announced that one […]
Rakuten Aspyrian Announces Name Change to Rakuten Medical
SAN MATEO, California, March 1, 2019 /PRNewswire/ — Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoimmunotherapy platform, today announced that […]
Pius S. Hornstein, PhD, Appointed New Country Chair of Sanofi China
SHANGHAI, March 1, 2019 /PRNewswire/ — Sanofi announced that Pius S. Hornstein, PhD, has been appointed the new General Manager China, China & Emerging Markets […]
